Cargando…
Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
Endocrine disrupting chemicals (EDCs), a heterogeneous group of exogenous chemicals that can interfere with any aspect of endogenous hormones, represent an emerging global threat for human metabolism. There is now considerable evidence that the observed upsurge of metabolic disease cannot be fully a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406073/ https://www.ncbi.nlm.nih.gov/pubmed/30881345 http://dx.doi.org/10.3389/fendo.2019.00112 |
_version_ | 1783401217525809152 |
---|---|
author | Papalou, Olga Kandaraki, Eleni A. Papadakis, George Diamanti-Kandarakis, Evanthia |
author_facet | Papalou, Olga Kandaraki, Eleni A. Papadakis, George Diamanti-Kandarakis, Evanthia |
author_sort | Papalou, Olga |
collection | PubMed |
description | Endocrine disrupting chemicals (EDCs), a heterogeneous group of exogenous chemicals that can interfere with any aspect of endogenous hormones, represent an emerging global threat for human metabolism. There is now considerable evidence that the observed upsurge of metabolic disease cannot be fully attributed to increased caloric intake, physical inactivity, sleep deficit, and ageing. Among environmental factors implicated in the global deterioration of metabolic health, EDCs have drawn the biggest attention of scientific community, and not unjustifiably. EDCs unleash a coordinated attack toward multiple components of human metabolism, including crucial, metabolically-active organs such as hypothalamus, adipose tissue, pancreatic beta cells, skeletal muscle, and liver. Specifically, EDCs' impact during critical developmental windows can promote the disruption of individual or multiple systems involved in metabolism, via inducing epigenetic changes that can permanently alter the epigenome in the germline, enabling changes to be transmitted to the subsequent generations. The clear effect of this multifaceted attack is the manifestation of metabolic disease, clinically expressed as obesity, metabolic syndrome, diabetes mellitus, and non-alcoholic fatty liver disease. Although limitations of EDCs research do exist, there is no doubt that EDCs constitute a crucial parameter of the global deterioration of metabolic health we currently encounter. |
format | Online Article Text |
id | pubmed-6406073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64060732019-03-15 Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease Papalou, Olga Kandaraki, Eleni A. Papadakis, George Diamanti-Kandarakis, Evanthia Front Endocrinol (Lausanne) Endocrinology Endocrine disrupting chemicals (EDCs), a heterogeneous group of exogenous chemicals that can interfere with any aspect of endogenous hormones, represent an emerging global threat for human metabolism. There is now considerable evidence that the observed upsurge of metabolic disease cannot be fully attributed to increased caloric intake, physical inactivity, sleep deficit, and ageing. Among environmental factors implicated in the global deterioration of metabolic health, EDCs have drawn the biggest attention of scientific community, and not unjustifiably. EDCs unleash a coordinated attack toward multiple components of human metabolism, including crucial, metabolically-active organs such as hypothalamus, adipose tissue, pancreatic beta cells, skeletal muscle, and liver. Specifically, EDCs' impact during critical developmental windows can promote the disruption of individual or multiple systems involved in metabolism, via inducing epigenetic changes that can permanently alter the epigenome in the germline, enabling changes to be transmitted to the subsequent generations. The clear effect of this multifaceted attack is the manifestation of metabolic disease, clinically expressed as obesity, metabolic syndrome, diabetes mellitus, and non-alcoholic fatty liver disease. Although limitations of EDCs research do exist, there is no doubt that EDCs constitute a crucial parameter of the global deterioration of metabolic health we currently encounter. Frontiers Media S.A. 2019-03-01 /pmc/articles/PMC6406073/ /pubmed/30881345 http://dx.doi.org/10.3389/fendo.2019.00112 Text en Copyright © 2019 Papalou, Kandaraki, Papadakis and Diamanti-Kandarakis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Papalou, Olga Kandaraki, Eleni A. Papadakis, George Diamanti-Kandarakis, Evanthia Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease |
title | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease |
title_full | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease |
title_fullStr | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease |
title_full_unstemmed | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease |
title_short | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease |
title_sort | endocrine disrupting chemicals: an occult mediator of metabolic disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406073/ https://www.ncbi.nlm.nih.gov/pubmed/30881345 http://dx.doi.org/10.3389/fendo.2019.00112 |
work_keys_str_mv | AT papalouolga endocrinedisruptingchemicalsanoccultmediatorofmetabolicdisease AT kandarakielenia endocrinedisruptingchemicalsanoccultmediatorofmetabolicdisease AT papadakisgeorge endocrinedisruptingchemicalsanoccultmediatorofmetabolicdisease AT diamantikandarakisevanthia endocrinedisruptingchemicalsanoccultmediatorofmetabolicdisease |